Article Data

  • Views 486
  • Dowloads 112

Original Research

Open Access

Synergistic effects of neuroendoscopic minimally invasive surgery with mannitol and furosemide in managing hypertensive intracerebral hemorrhage

  • Hui Xu1,*,†,
  • Jiangtao Dong1,†
  • Ganggang Wang1
  • Shilong Wang1
  • Huanhuan Dong2
  • Youjie Hu1

1Department of Neurosurgery, the First Affiliated Hospital of Shihezi University, 832000 Shihezi, Xinjiang Uygur Autonomous Region, China

2Department of Anesthesia for surgery, the First Affiliated Hospital of Shihezi University, 832000 Shihezi, Xinjiang Uygur Autonomous Region, China

DOI: 10.22514/sv.2024.061 Vol.20,Issue 5,May 2024 pp.94-100

Submitted: 07 February 2024 Accepted: 24 April 2024

Published: 08 May 2024

*Corresponding Author(s): Hui Xu E-mail: xh39037@163.com

† These authors contributed equally.

Abstract

This study aimed to assess the therapeutic efficacy of neuroendoscopic minimally invasive surgery combined with mannitol and furosemide for treating hypertensive intracerebral hemorrhage. We retrospectively analyzed clinical data from 200 patients with hypertensive intracerebral hemorrhage treated at our hospital between July 2020 and July 2022. The patients were categorized into either the experimental group (undergoing neuroendoscopic minimally invasive surgery combined with mannitol and furosemide) or the control group (undergoing neuroendoscopic minimally invasive surgery alone). Then, we compared the efficacy and impact on patients between the two groups. After treatment, the experimental group exhibited a smaller edema area compared to the control group and a reduced hematoma volume (p < 0.001). The total effective rate was significantly higher in the experimental group compared to the control group (p < 0.05). At 7 days post-treatment, patients in the experimental group demonstrated a significantly lower National Institutes of Health Stroke Scale (NIHSS) score compared to the control group (p < 0.001). Additionally, 3 and 7 days after treatment, levels of lipid peroxidation (LPO), neuron-specific enolase (NSE), and S-100β were significantly lower in the experimental group compared to the control group (p < 0.001). Similarly, carotid total blood flow volume (Q) and blood flow velocity (V) were significantly higher in the experimental group at 3 and 7 days post-treatment, with lower peripheral resistance (R) compared to the control group (p < 0.001). The incidence rate of complications was significantly lower in the experimental group compared to the control group (p < 0.05). The integration of neuroendoscopic minimally invasive surgery with mannitol and furosemide administration demonstrates potential in alleviating brain edema, reducing related cytokine levels, facilitating neurological function recovery, and improving cerebral hemodynamic parameters in hypertensive intracerebral hemorrhage patients. These findings merit clinical promotion and application.


Keywords

Neuroendoscopic minimally invasive surgery; Mannitol; Furosemide; Hypertensive intracerebral hemorrhage


Cite and Share

Hui Xu,Jiangtao Dong,Ganggang Wang,Shilong Wang,Huanhuan Dong,Youjie Hu. Synergistic effects of neuroendoscopic minimally invasive surgery with mannitol and furosemide in managing hypertensive intracerebral hemorrhage. Signa Vitae. 2024. 20(5);94-100.

References

[1] Li W, Li S, Li L, Yang L, Li Z, Li X, et al. Soyasaponin I alleviates hypertensive intracerebral hemorrhage by inhibiting the renin–angiotensin–aldosterone system. Clinical and Experimental Hypertension. 2023; 45: 2177667.

[2] Chao T, Min Z, Wei L. Meta-analysis of stereotactic hematoma removal and craniotomy hematoma removal in the treatment of hypertensive intracerebral hemorrhage in the elderly. Medicine. 2023; 102: e36533.

[3] Munir CA, Afia F, Saqlain MM. Letter to the editor: use of dyna-computed tomography-assisted neuro endoscopic hematoma evacuation in the treatment of hypertensive intracerebral hemorrhage. Neurosurgical Review. 2023; 46: 278.

[4] Zhu Z, Hao L, Gao L, Li X, Zhao J, Zhang T, et al. Determinants of acute and subacute case-fatality in elderly patients with hypertensive intracerebral hemorrhage. Heliyon. 2023; 9: e20781.

[5] Tian B, Tian B, Zhang Y. The efficacy of mannitol combined with 6-aminocaproic acid in the treatment of patients with cerebral hemorrhage and its impact on immune function. Evidence-Based Complementary and Alternative Medicine. 2022; 2022: 7396310.

[6] Waguespack T, Tucker N, Kimmons L, Jones GM. 994: Impact of early mannitol administration on hematoma size in intracerebal hemorrhage. Critical Care Medicine. 2022; 50: 494.

[7] Wang H, Tian L, Yang H, Chen K. Use of dyna-computed tomography-assisted neuroendoscopic hematoma evacuation in the treatment of hypertensive intracerebral hemorrhage. Neurosurgical Review. 2023; 46: 254.

[8] Zhan Y, Zou X, Wu J, Fu L, Huang W, Lin J, et al. Neuroendoscopy surgery for hypertensive intracerebral hemorrhage with concurrent brain herniation: a retrospective study of comparison with craniotomy. Frontiers in Neurology. 2023; 14: 1238283.

[9] Zhang CY, Wang B, Hua XT, Fan K, Li YF. Serum vascular endothelial growth factor and cortisol expression to predict prognosis of patients with hypertensive cerebral hemorrhage. World Journal of Clinical Cases. 2023; 11: 5455–5461.

[10] Li Q, Chen L. Effect of tibialis anterior muscle resistance training on ankle and foot dorsum extension function in hypertensive cerebral hemorrhage hemiplegia patients: a randomized controlled trial. Medicine. 2023; 102: e33827.

[11] Hongbo H, Xin L. Clinical changes of serum melatonin and ICAM-1 levels in patients with basal ganglia hypertensive intracerebral hemorrhage. Pakistan Journal of Medical Sciences. 2023; 39: 1024–1028.

[12] Anand S, Choudhury SS, Pradhan S, Mulmuley MS. Normotensive state during acute phase of hypertensive intracerebral hemorrhage. Journal of Neurosciences in Rural Practice. 2023; 14: 465–469.

[13] Lv K, Wang Y, Chao H, Cao S, Cao W. Comparison of the efficacy of subosseous window neuro-endoscopy and minimally invasive craniotomy in the treatment of basal ganglia hypertensive intracerebral hemorrhage. Journal of Craniofacial Surgery. 2023; 34: e724–e728.

[14] Yuan H, Feng J, Lin X, Li S. The effect of early vs. late CT-guided stereotactic hematoma aspiration on neurological function recovery in patients with hypertensive cerebral hemorrhage in the basal ganglia: a retrospective comparative cohort study. Annals of Palliative Medicine. 2022; 11: 2923–2929.

[15] Mao J, Xu Z, Sun Z, Xu M, Zhao B, Wei J, et al. The effect of small bone window craniotomy removal on lactic acid and CRP in patients with hypertensive intracerebral hemorrhage in the basal ganglia. Neurology India. 2022; 70: 2047–2052.

[16] Lu W, Wang H, Feng K, He B, Jia D. Neuroendoscopic-assisted versus mini-open craniotomy for hypertensive intracerebral hemorrhage: a retrospective analysis. BMC Surgery. 2022; 22: 188.

[17] Mei L, Fengqun M, Xiaozhuo L, Qing W, Mingming F, Zhengyao Z, et al. Effect western medicines combined with Nao-Xue-Shu in patients with hypertensive intracerebral hemorrhage: a network meta-analysis. Frontiers in Pharmacology. 2022; 13: 892904.

[18] Tingyan Hu, Zhao Y, Hu Z, Zuo C. Clinical effects of piracetam plus mannitol on cerebral edema, neurological function, and vascular endothelin-1 levels following cerebral hemorrhage. Neurochemical Journal. 2023; 17: 156–162.

[19] Schreibman DL, Hong CM, Keledjian K, Ivanova S, Tsymbalyuk S, Gerzanich V, et al. Mannitol and hypertonic saline reduce swelling and modulate inflammatory markers in a rat model of intracerebral hemorrhage. Neurocritical Care. 2018; 29: 253–263.

[20] Maykin MM, Mercer E, Saiki KM, Kaneshiro B, Miller CB, Tsai PS. Furosemide to lower antenatal severe hypertension: a randomized placebo-controlled trial. American Journal of Obstetrics & Gynecology MFM. 2024; 6: 101348.

[21] Liao R, Liu L, Song B, Wan X, Wang S, Xu J. 3D-slicer software-assisted neuroendoscopic surgery in the treatment of hypertensive cerebral hemorrhage. Computational and Mathematical Methods in Medicine. 2022; 2022: 7156598.

[22] Yang Y, Pan Y, Chen C, Zhao P, Hang C. Clinical significance of multiparameter intracranial pressure monitoring in the prognosis prediction of hypertensive intracerebral hemorrhage. Journal of Clinical Medicine. 2022; 11: 671.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time

Conferences

Top